Growing research points to that short protein approaches represent a exciting new horizon for tumor management. Unlike established chemotherapy, these treatments often be designed to specifically bind to cancer cells while minimizing damage to non-cancerous cells. This precision holds the potential for enhanced results and less toxicity for people